Uridine Triacetate (Xuriden), a new orphan drug approved to treat rare autosomal recessive disorder

Last Updated on

September 06, 2015 – The American Food and Drug Administration just approved Uridine Triacetate (Xuriden), the first FDA-approved treatment for patients with hereditary orotic aciduria. Hereditary orotic aciduria is a rare metabolic disorder, which has been reported in approximately 20 patients worldwide and which can be caused by a deficiency in the enzyme UMPS

Hereditary orotic aciduria is inherited from a recessive gene. The disease is due to a defective or deficient enzyme, which results in the body being unable to normally synthesize uridine, a necessary component of ribonucleic acid (RNA). Signs and symptoms of the disease include blood abnormalities (anemia, decreased white blood Autosomal recessive count, decreased neutrophil count), urinary tract obstruction due to the formation of orotic acid crystals in the urinary tract, failure to thrive, and developmental delays.

“Today’s approval and rare pediatric disease priority review voucher underscore the FDA’s commitment to making treatments available to patients with rare diseases,” said Amy G. Egan, M.D., M.P.H., deputy director of the Office of Drug Evaluation III in the FDA’s Center for Drug Evaluation and Research (CDER). “Prior to the approval of Uridine Triacetate (Xuriden), patients with this rare disorder had no approved treatment options.”

The FDA granted Uridine Triacetate (Xuriden) orphan drug designation because it treats a rare disease. Orphan drug designation provides financial incentives, like clinical trial tax credits, user fee waivers, and eligibility for market exclusivity to promote rare disease drug development. Uridine Triacetate (Xuriden) was also granted priority review. An FDA priority review provides for an expedited review of drugs for serious diseases or conditions that may offer major advances in treatment. The manufacturer of Uridine Triacetate (Xuriden) was granted a rare pediatric disease priority review voucher – a provision that encourages development of new drugs and biologics for the prevention and treatment of rare pediatric diseases.

Uridine Triacetate (Xuriden) is an orally administered product intended to replace uridine. Uridine Triacetate (Xuriden) is approved as oral granules that can be mixed with food or in milk or infant formula, and is administered once daily. The safety and effectiveness of Uridine Triacetate (Xuriden) were evaluated in a single arm, six-week, open-label trial in four patients with hereditary orotic aciduria, ranging in age from three to 19 years of age, and in a six-month extension phase of the trial. The study assessed changes in the patients’ pre-specified hematologic parameters during the trial period. At both the six-week and six-month assessments, Uridine Triacetate (Xuriden) treatment resulted in stability of the hematologic parameters in all four clinical trial patients. The safety and effectiveness of uridine replacement therapy were further supported by case reports from the published literature.

 

Tags: , , , , , ,
About the Author
Joseph Gut - thasso Ph.D.; Professor in Pharmacology and Toxicology. Senior expert in theragenomic and personalized medicine and individualized drug safety. Senior expert in pharmaco- and toxicogenetics. Senior expert in human safety of drugs, chemicals, environmental pollutants, and dietary ingredients.

Your opinion

Comment

No comments yet

thasso: conditions

thasso: newest tweets

thasso: recent comments

thasso post: magazine

View my Flipboard Magazine.

thasso: categories

thasso: archives

thasso: simple chat

You must be a registered user to participate in this chat.

  • New CRISPR advance may solve key quandary June 2, 2020
    A mutation unique to certain cancer tumors is a potential homing beacon for safely deploying CRISPR gene editing enzymes to disarm DNA that makes cancer cells resistant to treatment, while ignoring the gene in normal cells where it's critical to healthy function, according to a new study from ChristianaCare's Gene Editing Institute in the journal […]
  • Gene discovery in fruit flies 'opens new doors' for hearing loss cure in elderly June 2, 2020
    Scientists at UCL have discovered sets of regulatory genes, which are responsible for maintaining healthy hearing. The finding, made in fruit flies, could potentially lead to treatments for age-related hearing loss (ARHL) in humans.
  • Study reveals how a master regulator of gene transcription operates June 2, 2020
    Using targeted protein degradation technology, researchers at CeMM, the Research Center for Molecular Medicine of the Austrian Academy of Sciences, set out to understand the primary role of a key regulator of transcription, the human Mediator complex. Mediator, a 30-subunit molecular machine, was believed to be a factor that is generally required for the transcription […]
  • Genetic cause of difference in sexual development uncovered June 1, 2020
    Researchers at the Francis Crick Institute, the Institut Pasteur and their clinical collaborators have identified a cause of testicular tissue developing in people with female chromosomes.
  • The interface of genomic information with the electronic health record June 1, 2020
    Advances in genetic and genomic testing technology have not only introduced the utilization of clinical genomic information into virtually every area of medical care, this testing has become an essential tool to achieve the goal of precision medicine. As genomic data become more complex, so too must the electronic health record (EHR) evolve to provide […]
  • Piecing together the Dead Sea Scrolls with DNA evidence June 2, 2020
    Piecing together the collection of more than 25,000 fragments of ancient manuscripts known as the Dead Sea Scrolls in order to understand their meaning has remained an incredibly difficult puzzle. Now, researchers reporting in the journal Cell on June 2 have used an intriguing clue to help in this effort: DNA "fingerprints" lifted from the […]
  • Bees grooming each other can boost colony immunity June 2, 2020
    Honeybees that specialise in grooming their nestmates (allogroomers) to ward off pests play a central role in the colony, finds a new UCL and University of Florence study published in Scientific Reports.
  • Extracellular vesicles play an important role in the pathology of malaria vivax June 2, 2020
    Extracellular vesicles (EVs) play a role in the pathogenesis of malaria vivax, according to a study led by researchers from the Barcelona Institute for Global Health (ISGlobal) and the Germans Trias i Pujol Health Science Research Institute (IGTP). The findings, published in Nature Communications, indicate that EVs from P. vivax patients communicate with spleen fibroblasts […]
  • When determining sex, exceptions are the rule June 2, 2020
    Thanks to new genomic data, long-held theories on sex chromosome evolution are now being tested against empirical evidence from nature -- often with surprising results.
  • Carnegie Mellon tool automatically turns math into pictures June 2, 2020
    Some people look at an equation and see a bunch of numbers and symbols; others see beauty. Thanks to a new tool created at Carnegie Mellon University, anyone can now translate the abstractions of mathematics into beautiful and instructive illustrations. The tool enables users to create diagrams simply by typing an ordinary mathematical expression and […]
Top